GLP1R and diabetic kidney disease: Additionally, C-peptide, which was found to inhibit tubulointerstitial fibrosis [7], was increased by GLP-1 Ras, suggesting a potential mechanism of improving tubulointerstitial and tubular injury in GK rats with diabetic nephropathy [6].